The Social Network THESN
Résultats de Recherche
Voir tous les résulats
  • Nous rejoindre
    Identifiant S’inscrire
    Day Mode

Rechercher

Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis

  • FAVORIS
  • Fil d’actualités
  • EXPLORE
  • Pages
  • Groupes
  • Evénements
  • Blogs
  • Financement
  • Forums
  • Articles
  • Articles
  • Utilisateurs
  • Pages
  • Groupes
  • Evénements
  • Kan Kumar added new article
    2025-09-16 07:47:46 -
    Beyond the Immune Surge: IL Inhibitors in Development
    The therapeutic landscape for immune-mediated disorders has undergone a dramatic transformation through interleukin inhibitors, which have progressed from specialized niche treatments to cornerstone targeted therapies across diverse medical specialties. The Interleukin Inhibitors Market currently demonstrates a well-established foundation of regulatory-approved agents, a comprehensive...
    0 Commentaires 0 parts
    Please log in to like, share and comment!
  • John Snow added new article
    2025-06-23 07:47:55 -
    Cancer Anorexia Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Helsinn Healthcare, Artelo Biosciences, NGM Biopharma
    DelveInsight’s “Cancer Anorexia Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Cancer Anorexia, historical and forecasted epidemiology as well as the Cancer Anorexia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.   To Know in detail about the Cancer Anorexia...
    0 Commentaires 0 parts
    Please log in to like, share and comment!
  • Kan Kumar added new article
    2025-09-18 17:29:34 -
    LAG-3 Immunotherapy Market: Strategic Opportunities
    The LAG-3 Market has moved from a niche immunology focus to a key area in oncology, immuno-oncology combinations, and autoimmune disease research. Interest beyond PD-1/PD-L1 checkpoints has grown, supported by stronger biological insights, expanding clinical pipelines, and data suggesting better outcomes when LAG-3 modulation is used with other therapies. Scientific and clinical backgroundLAG-3...
    0 Commentaires 0 parts
    Please log in to like, share and comment!
© 2025 The Social Network THESN French
English French Dutch
About Conditions Confidentialité Contact Us Annuaire